Skip to main content
Erschienen in: Lung 6/2010

01.12.2010

Pleuropericarditis in a Patient with Inflammatory Bowel Disease: A Case Presentation and Review of the Literature

verfasst von: Muhanned Abu-Hijleh, Samuel Evans, Bassam Aswad

Erschienen in: Lung | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Inflammatory bowel disease (IBD) can affect the lung parenchyma and airways. Rarely it involves the pleural space and pericardium, causing inflammatory exudative pleural and/or pericardial effusions. In this report, we describe a 76-year-old patient with recurrent sterile exudative pleuropericarditis that gradually responded to treatment with steroids, and we review the relevant literature. Thoracic serositis in patients with IBD can cause pleuritis, pericarditis, pleuropericarditis, or myopericarditis. This is a relatively rare presentation of the uncommon and probably underreported and underrecognized pulmonary extraintestinal manifestations of IBD. Pleuropericardial inflammatory disease and effusion can be directly related to IBD, its complications, associated infections, or the medications used to treat it. Serositis directly related to IBD is a diagnosis of exclusion. It is important to evaluate the pleural effusion and rule out other etiologies before making this diagnosis. Pleural or pericardial biopsies are rarely necessary, and probably show nonspecific acute and chronic inflammatory changes. Although the specific pathophysiology of pleuropericardial disease in patients with IBD remains unclear, the response to systemic steroids is usually adequate.
Literatur
1.
Zurück zum Zitat Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517CrossRefPubMed Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517CrossRefPubMed
2.
Zurück zum Zitat Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5(12):1424–1429CrossRefPubMed Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5(12):1424–1429CrossRefPubMed
3.
Zurück zum Zitat Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39(5):690–697CrossRefPubMed Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39(5):690–697CrossRefPubMed
4.
Zurück zum Zitat Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183 Camus P, Piard F, Ashcroft T, Gal AA, Colby TV (1993) The lung in inflammatory bowel disease. Medicine (Baltimore) 72(3):151–183
5.
Zurück zum Zitat Storch I, Sachar D, Katz S (2003) Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 9(2):104–115CrossRefPubMed Storch I, Sachar D, Katz S (2003) Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 9(2):104–115CrossRefPubMed
6.
Zurück zum Zitat Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219CrossRefPubMed Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV (2003) Noninfectious lung pathology in patients with Crohn’s disease. Am J Surg Pathol 27(2):213–219CrossRefPubMed
7.
Zurück zum Zitat Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A (2008) Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung 186(3):167–172CrossRefPubMed Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A (2008) Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung 186(3):167–172CrossRefPubMed
8.
Zurück zum Zitat Kraft SC, Earle RH, Roesler M, Esterly JR (1976) Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136(4):454–459CrossRefPubMed Kraft SC, Earle RH, Roesler M, Esterly JR (1976) Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136(4):454–459CrossRefPubMed
9.
Zurück zum Zitat Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ (1983) Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 143(1):94–96CrossRefPubMed Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ (1983) Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 143(1):94–96CrossRefPubMed
10.
Zurück zum Zitat Rosenbaum AJ, Murphy PJ, Engel JJ (1983) Pleurisy during the course of ulcerative colitis. J Clin Gastroenterol 5(6):517–521CrossRefPubMed Rosenbaum AJ, Murphy PJ, Engel JJ (1983) Pleurisy during the course of ulcerative colitis. J Clin Gastroenterol 5(6):517–521CrossRefPubMed
11.
Zurück zum Zitat Abid MA, Gitlin N (1990) Pericarditis—an extraintestinal complication of inflammatory bowel disease. West J Med 153(3):314–315PubMed Abid MA, Gitlin N (1990) Pericarditis—an extraintestinal complication of inflammatory bowel disease. West J Med 153(3):314–315PubMed
12.
Zurück zum Zitat Bernstein CN, Wajda A, Blanchard JF (2005) The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129(3):827–836CrossRefPubMed Bernstein CN, Wajda A, Blanchard JF (2005) The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129(3):827–836CrossRefPubMed
13.
Zurück zum Zitat Black H, Mendoza M, Murin S (2007) Thoracic manifestations of inflammatory bowel disease. Chest 131(2):524–532CrossRefPubMed Black H, Mendoza M, Murin S (2007) Thoracic manifestations of inflammatory bowel disease. Chest 131(2):524–532CrossRefPubMed
14.
Zurück zum Zitat Ho GT, Innes JA, Shand AG, Satsangi J (2006) Bronchopulmonary manifestations of inflammatory bowel disease: a case report and literature review. J R Coll Phys Edin 36:299–303 Ho GT, Innes JA, Shand AG, Satsangi J (2006) Bronchopulmonary manifestations of inflammatory bowel disease: a case report and literature review. J R Coll Phys Edin 36:299–303
15.
Zurück zum Zitat Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C (1985) Evidence of lymphocyte alveolitis in Crohn’s disease. Chest 87(3):363–367CrossRefPubMed Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C (1985) Evidence of lymphocyte alveolitis in Crohn’s disease. Chest 87(3):363–367CrossRefPubMed
16.
Zurück zum Zitat Smiéjan JM, Cosnes J, Chollet-Martin S, Soler P, Basset FM, Le Quintrec Y, Hance AJ (1986) Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn’s disease. Ann Intern Med 104(1):17–21PubMed Smiéjan JM, Cosnes J, Chollet-Martin S, Soler P, Basset FM, Le Quintrec Y, Hance AJ (1986) Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn’s disease. Ann Intern Med 104(1):17–21PubMed
17.
Zurück zum Zitat Adenis A, Colombel JF, Lecouffe P, Wallaert B, Hecquet B, Marchandise X, Cortot A (1992) Increased pulmonary and intestinal permeability in Crohn’s disease. Gut 33(5):678–682CrossRefPubMed Adenis A, Colombel JF, Lecouffe P, Wallaert B, Hecquet B, Marchandise X, Cortot A (1992) Increased pulmonary and intestinal permeability in Crohn’s disease. Gut 33(5):678–682CrossRefPubMed
18.
Zurück zum Zitat Mohammed AR, Babu S (2008) Serositis and inflammatory bowel disease. Br J Hosp Med (Lond) 69(5):296–297 Mohammed AR, Babu S (2008) Serositis and inflammatory bowel disease. Br J Hosp Med (Lond) 69(5):296–297
19.
Zurück zum Zitat Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA (1988) Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 43(9):735–736CrossRefPubMed Swinburn CR, Jackson GJ, Cobden I, Ashcroft T, Morritt GN, Corris PA (1988) Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 43(9):735–736CrossRefPubMed
20.
Zurück zum Zitat Faller M, Gasser B, Massard G, Pauli G, Quoix E (2000) Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration 67(4):459–463CrossRefPubMed Faller M, Gasser B, Massard G, Pauli G, Quoix E (2000) Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn’s disease. Respiration 67(4):459–463CrossRefPubMed
21.
Zurück zum Zitat Haralambou G, Teirstein AS, Gil J, Present DH (2001) Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 68(6):384–388PubMed Haralambou G, Teirstein AS, Gil J, Present DH (2001) Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 68(6):384–388PubMed
22.
Zurück zum Zitat Parry SD, Barbatzas C, Peel ET, Barton JR (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4):756–764CrossRefPubMed Parry SD, Barbatzas C, Peel ET, Barton JR (2002) Sulphasalazine and lung toxicity. Eur Respir J 19(4):756–764CrossRefPubMed
23.
Zurück zum Zitat Mukhopadhyay D, Nasr K, Grossman BJ, Kirsner JB (1970) Pericarditis associated with inflammatory bowel disease. JAMA 211(9):1540–1542CrossRefPubMed Mukhopadhyay D, Nasr K, Grossman BJ, Kirsner JB (1970) Pericarditis associated with inflammatory bowel disease. JAMA 211(9):1540–1542CrossRefPubMed
24.
Zurück zum Zitat Breitenstein RA, Salel AF, Watson DW (1974) Chronic inflammatory bowel disease: acute pericarditis and pericardial tamponade [letter]. Ann Intern Med 81(3):406PubMed Breitenstein RA, Salel AF, Watson DW (1974) Chronic inflammatory bowel disease: acute pericarditis and pericardial tamponade [letter]. Ann Intern Med 81(3):406PubMed
25.
Zurück zum Zitat Thompson DG, Lennard-Jones JE, Swarbrick ET, Bown R (1979) Pericarditis and inflammatory bowel disease. Q J Med 48(189):93–97PubMed Thompson DG, Lennard-Jones JE, Swarbrick ET, Bown R (1979) Pericarditis and inflammatory bowel disease. Q J Med 48(189):93–97PubMed
26.
Zurück zum Zitat Puntis JW, Tarlow MJ, Raafat F, Booth IW (1990) Crohn’s disease of the lung. Arch Dis Child 65(11):1270–1271CrossRefPubMed Puntis JW, Tarlow MJ, Raafat F, Booth IW (1990) Crohn’s disease of the lung. Arch Dis Child 65(11):1270–1271CrossRefPubMed
27.
Zurück zum Zitat Orii S, Chiba T, Nakadate I, Fujiwara T, Ito N, Ishii M, Oana S, Chida T, Kudara N, Terui T, Yamaguchi T, Suzuki K (2001) Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis. J Clin Gastroenterol 32(3):251–254CrossRefPubMed Orii S, Chiba T, Nakadate I, Fujiwara T, Ito N, Ishii M, Oana S, Chida T, Kudara N, Terui T, Yamaguchi T, Suzuki K (2001) Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis. J Clin Gastroenterol 32(3):251–254CrossRefPubMed
28.
Zurück zum Zitat Stajer D, Gorjup V (1996) Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism. Intensive Care Med 22(10):1134–1135CrossRefPubMed Stajer D, Gorjup V (1996) Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism. Intensive Care Med 22(10):1134–1135CrossRefPubMed
Metadaten
Titel
Pleuropericarditis in a Patient with Inflammatory Bowel Disease: A Case Presentation and Review of the Literature
verfasst von
Muhanned Abu-Hijleh
Samuel Evans
Bassam Aswad
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 6/2010
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9259-y

Weitere Artikel der Ausgabe 6/2010

Lung 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.